140 related articles for article (PubMed ID: 2652080)
21. The role of alpha interferon in the biotherapy of hematologic malignancies and AIDS-related Kaposi's sarcoma.
Mitsuyasu RT
Oncol Nurs Forum; 1988; 15(6 Suppl):7-12. PubMed ID: 3060868
[No Abstract] [Full Text] [Related]
22. [Therapeutic use of interferon: current trends and prospects].
Laghi V; Toccaceli F
Medicina (Firenze); 1990; 10(2):201-11. PubMed ID: 1703261
[No Abstract] [Full Text] [Related]
23. [Interferon and therapy of oncological diseases].
Andzhaparidze OG; Pille ER
Vopr Virusol; 1989; 34(5):517-23. PubMed ID: 2481902
[No Abstract] [Full Text] [Related]
24. [Interferon (IFN) in multiple myeloma and non-Hodgkin's lymphoma].
Gola A
Acta Haematol Pol; 1994; 25(2 Suppl 1):136-41. PubMed ID: 7520658
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease].
Stadler R; Bratzke B; Orfanos CE
Hautarzt; 1987 Aug; 38(8):453-60. PubMed ID: 3654216
[TBL] [Abstract][Full Text] [Related]
26. [Clinical effects of human fibroblast interferon on malignant tumors].
Ezaki K; Okabe K; Inagaki J; Horikoshi N; Inoue K; Aiba K; Domyo M; Nagata T; Ogawa M
Gan To Kagaku Ryoho; 1982 Jan; 9(1):31-7. PubMed ID: 7184362
[TBL] [Abstract][Full Text] [Related]
27. Recombinant alpha interferons 1986: a review.
Lindquist DL; Burns CP
Iowa Med; 1987 Jan; 77(1):32, 34, 36. PubMed ID: 3818250
[No Abstract] [Full Text] [Related]
28. [Treatment of hematologic diseases with alpha interferon].
Castaigne S
Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
[TBL] [Abstract][Full Text] [Related]
29. Biotherapy with interferon in AIDS-related Kaposi's sarcoma.
Mitsuyasu RT; Miles SA
Oncol Nurs Forum; 1987; 14(6 Suppl):27-31. PubMed ID: 3320983
[No Abstract] [Full Text] [Related]
30. [Bone marrow transplantation--rapid development towards new indications].
Gahrton G; Ringdén O; Robert KH
Lakartidningen; 1988 Mar; 85(9):689-91, 695. PubMed ID: 3280928
[No Abstract] [Full Text] [Related]
31. Update on haematologic malignancy.
Jacobs P
Cent Afr J Med; 1986 Apr; 32(4):100-6. PubMed ID: 3791396
[No Abstract] [Full Text] [Related]
32. Interferons as anticancer agents.
Brodsky I; Hubbell HR
Am Fam Physician; 1984 Jun; 29(6):246-8. PubMed ID: 6203394
[No Abstract] [Full Text] [Related]
33. Non-Hodgkin lymphoma and skin cancer: A dangerous combination.
Otley CC
Australas J Dermatol; 2006 Nov; 47(4):231-6. PubMed ID: 17034463
[TBL] [Abstract][Full Text] [Related]
34. The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma.
Berg JW
J Natl Cancer Inst; 1967 May; 38(5):741-52. PubMed ID: 5229351
[No Abstract] [Full Text] [Related]
35. Studies on antiviral and antitumor effects of human leukocyte interferon in vitro and in vivo.
Strander H; Cantell K
In Vitro Monogr; 1974; (3):49-56. PubMed ID: 4471024
[No Abstract] [Full Text] [Related]
36. Cancer in AIDS.
Curr Opin Oncol; 1998 Sep; 10(5):B160-3. PubMed ID: 9800123
[No Abstract] [Full Text] [Related]
37. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
[No Abstract] [Full Text] [Related]
38. [Aspects of molecular remission in hematology and oncology].
Novik AA; Kamilova TA; Tsygan VN
Vopr Onkol; 2001; 47(3):270-7. PubMed ID: 11544823
[No Abstract] [Full Text] [Related]
39. Alpha interferon: a look to the future.
Bonnem EM
Invest New Drugs; 1987; 5 Suppl():S65-75. PubMed ID: 3298135
[TBL] [Abstract][Full Text] [Related]
40. Urinary enzyme excretion during treatment of malignancies with human recombinant alpha-2 interferon.
Metz-Kurschel U; Kurschel E; Niederle N; Scheulen ME; Graben N
Nephrol Dial Transplant; 1987; 2(6):515-9. PubMed ID: 2894618
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
